chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient's healthcare provider recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2012, a physician administered ZOSTAVAX, (lot# and route unknown) to the patient. The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related injuries. In 2013, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. The patient used the ZOSTAVAX vaccine for the permanent prevention of shingles and zoster-related injuries. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
Symptoms included a hard bump with bruising at the injection site. Patient took Tylenol and applied ice packs which alleviated most symptoms, patient still has bruising.
Pt. fainted immediately after receiving Gardasil and Menactra.  Hit mouth-injury gum & cutting lip.  Contusion on cheek and forehead.
My entire arm, from my shoulder to my fingertips, went numb around 12 hours after the shot.
Had Pfizer dose #1 on 12-18-2020 and Pfizer dose #2 on 1-8-2021.  Experienced a miscarriage at 9 weeks in June 2021 (first miscarriage) and had a D&C on 6-10-2021.  received 3rd dose of Pfizer vaccine (booster) on 9-28-2021.  Experienced a second miscarriage on 12-20-2021 and took cytotec medication twice and did three doses of methergine for treatment.
This spontaneous report was received from a healthcare professional and refers to a currently 12 months old, female patient. The patient's medical history and concurrent conditions were not reported. On 05-OCT-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) lot # L008270 with expiration date 11-MAR-2017 (dose, and route of administration were not provided). No concomitant medications were reported. No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected as all scheduled follow up information was received.
I started with symptoms at 11 days post vaccine. It lasted three weeks. Intense itching that would wake me up at night. There would be no rash. I would wake up itching, put some hydrocortisone on and in the morning I would be fine, and this happened daily for three weeks. I saw Nurse Practitioner in my doctor's office - she recommended I stop my supplements and I was going in to the placebo week of my birth control and I stopped and within a couple of days I had no more itching. Since then I restarted my birth control on schedule and have slowly introduced each of my supplements (one at a time) and today was the last one to introduce and that was the fiber and I started that today. So far, I have had no symptoms that I had before.
No additional AEs; Inappropriate schedule of vaccine administered; This spontaneous report was received from a pharmacist and a consumer concerning to a female patient of unknown age.  The patient's concurrent conditions included chronic lung disease. No information regarding the patient's pertinent medical history, historical drugs, drug reactions, allergies or concomitant therapies was provided.      On an unspecified date in 2014, the patient was vaccinated with dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23), 1 time dose for prophylaxis (formulation, strength, dose, vaccination scheme, route of administration, anatomical site of vaccination, lot number and expiration date were not provided).             On 11-JAN-2021, the patient was vaccinated with a second dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23), 1 time dose for prophylaxis (formulation, strength, dose, vaccination scheme, route of administration, anatomical site of vaccination, lot number and expiration date were not provided).  It was reported that the patient's healthcare professional (HCP) recommended and requested that she receive the vaccine pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) every 5 years (previously reported as ''every 6 years'').
i got my firs dose of de vaccine on april 14.. and didnt get the second; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (i got my firs dose of de vaccine on april 14.. and didnt get the second) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (i got my firs dose of de vaccine on april 14.. and didnt get the second). At the time of the report, PRODUCT DOSE OMISSION ISSUE (i got my firs dose of de vaccine on april 14. and didnt get the second) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment details were provided.
On APRIL 1, 15 days after injection, I developed chest pressure and a burning sensation in the area of my sternum. The pressure worsened the next day to the point I asked to be taken to the ED at the hospital. My blood pressure was 187/92, I had some irregularities in my EKG. After lab tests for cardiac issues it was determined I was not having a heart attack. I then met with my PCP on April 7 to discuss this. We were wondering if it was anxiety. During this time from April 1 to present I have had marked soreness in both underarm lymph nodes and intermittent chest pressure. After another exchange with my PCP she confirmed that it could also be a possible response to the Moderna vaccine #1. Today, April 14, I had an echocardiogram stress test that was equivocal and it was determined to be safe, I should have a CT scan to make sure there is no issues in the arteries.  The cardiologist also agreed this could be an "inflammatory response" to the vaccine even though I was highly anxious during the test.  I say this to be fair and not wearing blinders. I would like to point out that the morning I awoke with chest pain, I was not experiencing anxiety. That came after my worry about what could be causing  it. I am only completing this form now because I feel it warrants the idea that there is vaccine involvement. By the age of 59 you tend to know your body. Thank you.
After receiving vaccine pt had Jerky movements for 2 to 4 minutes and then he felt ok. Pt stated that he had some pain in the arm after the shot and felt dizzy and can not remember anything until he felt better.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2015, the patient was inoculated with ZOSTAVAX for routine adult health maintenance for the prevention of shingles (strength, route, dosage schedule, and lot number were not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. In 2015, the patient was treated for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages (injury), and required extensive medical care and treatment. As a further proximate result, the patient suffered  and continued suffering significant medical expenses, pain, suffering (emotional distress) and other damages on unspecified dates (not recovered). The final outcome of the events was not specified and they were considered to be related to ZOSTAVAX.
This case was considered medically important. Information regarding PREVNAR 13 was received from a health care professional regarding a 6-month-old male patient who experienced erythema multiforme. At 6 months of age, the patient received the first dose on 07-Jul-2010 along with a dose of PENTACEL (Aventis-Pasteur), a dose of rotavirus vaccine (manufacturer unknown) and a dose of Hepatitis B vaccine (manufacturer unknown). On 09-Jul-2010, the patient experienced erythema multiforme characterized by "a full blown rash", without lesions or mouth lesions. No treatment was required. The patient was not hospitalized. The reporter considered the patient outcome as recovered (Jul-2010), since the parents (both physicians) have not contacted the office further. The physician noted that for further vaccine administration, she would consider giving one vaccine at a time in order to observe for any further reactions. No additional information was available at the time of this report.
diabetic; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID.  A female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunisation; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunisation; Bnt162b2 nos (DOSE NUMBER UNKNOWN (BOOSTER), SINGLE), for COVID-19 immunisation. The following information was reported: DIABETES MELLITUS (medically significant), outcome "unknown", described as "diabetic". Clinical course: Reporter said that they got their Pfizer vaccine at (withheld), but they only had the Moderna for this year. So her mother and she were trying to find out where they can get the Pfizer vaccine this year, and they both had several vaccines. She mentioned her mother was diabetic, and she had sarcoidosis. They had several vaccines, their cards full front and back, because they both had the extra boosters, they wanted to continue with Pfizer and didn't want to get a different brand, and they wanted to stay consistent. Provided the website for vaccine appointments.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300171511 Same reporter/product, different patient/event;
This case was reported by a physician via sales rep and described the occurrence of injection site erythema in a male patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a day after receiving SHINGRIX, the patient experienced injection site erythema, injection site pain, myalgia and fever. On an unknown date, the outcome of the injection site erythema, injection site pain, myalgia and fever were recovered/resolved. It was unknown if the reporter considered the injection site erythema, injection site pain, myalgia and fever to be related to SHINGRIX. Additional details were provided as follows: The patient experienced increased temperature. It was reported that all of the adverse events resolved within 8 hours of vaccination and the patient did not require any medical treatment. The healthcare professional provided the adverse events information to the sales representative during the visit. The sales representative was unable to document this herself so she contacted the call center to submit on her behalf.
Mom telephoned county health dept on 1/14/2000, stating that client developed symptoms on 01/01/2000. Rash appeared on scalp and palms of hands. Rash was very painful and itching. Client saw MD and also, saw another MD for treatment of symptoms.
Chills , bone and muscle aches, upper and lower lips went numb on left side for 5 hours or so.
This spontaneous report as received from a registered nurse refers to a patient of unknown age. On an unknown date the patient was vaccinated with a second dose of VAQTA (25U, lot number not provided) four months after the first dose was administered. No other co-suspects were reported. No concomitant medications were reported. No adverse symptoms reported. It was unspecified if the patient had sought medical attention. Additional information has been requested.
Left armpit and  shoulder near the collar bone hurt.  Both are tender to touch.  The armpit is swollen , looks like an egg shape and hurts from the shoulder to the breaat. Very uncomfortable.  Headache,  tired, body aches - this is ok.
redness in right arm; swelling in right arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness in right arm) and PERIPHERAL SWELLING (swelling in right arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048H21H) for COVID-19 vaccination.     No relevant medical history was provided by the reporter.     On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced ERYTHEMA (redness in right arm) and PERIPHERAL SWELLING (swelling in right arm). At the time of the report, ERYTHEMA (redness in right arm) and PERIPHERAL SWELLING (swelling in right arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication was reported.
Pt. received Moderna vaccine 03/24/2021. Pfizer vaccine was given 10/06/2021.
8 yo female with history of seizure disorder; seizure free on trileptal for 2 years, had seizure 2 days after receiving Hep A and Influenza
son had the shot 2 days later that young man was dead; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: Private  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), 2 days after the suspect product(s) administration, outcome "fatal", described as "son had the shot 2 days later that young man was dead". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: son had the shot 2 days later that young man was dead
The vaccine was administered after the 6 hour expiration window.  The vial was mixed that day at 10:50am and administered between 5:00-5:10pm.
This spontaneous report as received from a consumer refers to a 20 year old male patient. In MAY 2017 the patient was vaccinated with GARDASIL 9 for prophylaxis. In July -2017 the patient experienced anogenital warts. The outcome of anogenital warts was reported as recovering/resolving.
After receiving his second Moderna Vaccine the patient developed severe muscle cramps, metallic taste, agitation/loss of sleep, and stomach upset. He noticed an increase in stooling after eating, however stools were solid. The muscle cramps and mood changes mostly subsided after 7 days, however on day 8 (5/27/21) he was still experiencing taste changes, gi upset, and was having difficulty sleeping. I guided the patient on some symptom relieve and instructed him to contact the pharmacy or his doctor if the symptoms worsened or did not resolve within another 7 days. He felt he was on his way to the symptoms improving and would report any changes.
At 10:10 AM pt complained of dizziness + feeling very hot.  RN assessed patient + obtained vitals.  At 10:42AM BP was 160/100, OxSat. 98% RA, HR 104, Bottle water was given to patient.  Patient stated she was starting to feel better.  Patient to wait another 15' in monitoring area. Pt. denied any symptoms on the first dose of the Pfizer vaccine.  Pt. was re-assessed and vitals were taken @ 11:00 AM: BP 140/90, HR 85, OxSat RA 70%.  Pt denied feeling any dizziness.  Pt. was released from monitoring area.  EMT walked pt out the exit and pt. had no further complications.  Nursing supervisor notified.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2014, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) for routine adult health maintenance and for the long-term prevention of shingles.  The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. In 2015, the patient was treated at a medical center for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Extreme swelling at injection site. Raised; Redness all over upper arm; HOT to touch; Hard, Tight skin; Painful. 5pm when I got home from work; took him to a walk-in clinic to be seen; marked the red mark on the upper arm in pen, 8pm. 10pm, the redness had grown outside the marks, Marked again. When he woke at 7am, Wednesday, the redness had grown again and marked again. On Thursday, skin tones in face were blotchy and yellowish. Arm not as red, still HOT to touch and arm was about 3x harder than other arm in comparison. Felt tight. He has been taking Keflex 3 times a day since walk-in on Tuesday. His demeanor is off, did not play outside for a day and a half which is very out of character.
This case was reported by a pharmacist via sales rep and described the occurrence of back pain in a female patient who received SHINGRIX for prophylaxis. On 9th November 2018, the patient received the 1st dose of SHINGRIX. On 9th November 2018, less than a day after receiving SHINGRIX, the patient experienced back pain, injection site pain and pain in arm. On an unknown date, the outcome of the back pain, injection site pain and pain in arm were unknown. It was unknown if the reporter considered the back pain, injection site pain and pain in arm to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient received the SHINGRIX vaccine and on the same day the patient experienced back pain, pain radiating from the injection site down her arm. The patient refused to get the 2nd dose. This case has been linked to cases US2018226062 and US2018226065, reported by the same reporter.
death Acute kidney failure, unspecified COVID-19 Acute respiratory failure with hypoxia Pneumonia due to coronavirus disease 2019
arm is sore; pain in her chest as she had before/pain in chest to her left upper sternal border area (under collar bone); fatigued; chills; fever; body aches, it was more like body cramping; body aches, it was more like body cramping; This is a spontaneous report from a contactable nurse (patient). A 57-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK9231 and expiry date: unknown), intramuscular on the left deltoid, on 14Jan2021 07:15 at a single dose for COVID-19 immunization. The first dose was received on 28Dec2020 (lot number: EK9231), intramuscular on the left deltoid and patient experienced sore arm, and left upper (under collar bone) pain in her chest. The patient medical history was not reported. There were no concomitant medications. She received the vaccine around 7:15 in the morning and by midnight on 15Jan2021 (she works nights), she started to feel the pain. By that point, she was like "ooh, my arm is sore". She also started to have the same pain in her chest as she had before (pain in chest to her left upper sternal border area (under collar bone). Her doctor ordered a chest x-ray on 25Jan2021. Patient stated it was not cardiac. It's just there. The pain was annoying and she can feel it when she moves or when she goes to get up, it's an ache. Its a pain in the neck. On Friday, 15Jan2021, she was real fatigued, had chills, a little bit of a fever, and body aches. She clarified it was more like body cramping and her body hurt so bad. She over that by Sunday.All of her symptoms resolved by Sunday 17Jan2021, except for the pain she was experiencing in her chest which was still ongoing and persisting. She had taken Tylenol, Aleve, and Ibuprofen, but it doesn't resolve the pain at all. Outcome of the event of sore arm was unknown, for pain in chest was not recovered while for the remaining events was recovered on 17Jan2021.
Exactly one week after shot developed pain in back left flank. Over several days it moved to left side and front. One week later a rash developed. It is diagnosed as shingles. I?m now on Valtrex .   I was also working night shift for several months which also may be the cause.  I submit this because I?m not stressed. I don?t get sick. Maybe my immunity was suppressed by vaccine.
Patient reported redness extending from shoulder to elbow and some warmth to touch that lasted from injection date to current date
49 YEARS OLD FEMALE HX OF HTN, HTN.  REPORTS HAVE NOT TAKEN BP MEDS X SEVERAL WEAKS IN OBSERVATION AREA REPORTS DIZZINESS, HEADACHE AND NAUSEA (PATIENT REPORTS HAVING SIMILAR SYMPTOMS 2 DAYS AGO) 14:40 197/94 HR 88 SPO2: 98% RR :14 14:50 196/101 HR 87 SPO2:99% RR:14 15:01 201/100 HR 94 SPO2 99% RR:16 EMS NOTIFIED ARRIVED AT 15:13. PT TRANSPORTED